Method of treating hepatic fibrosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7060709
APP PUB NO 20040242621A1
SERIAL NO

10767824

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides the use of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) in the treatment or inhibition of hepatic fibrosis and hepatic cirrhosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WYETHFIVE GIRALDA FARMS MADISON NJ 07940 UNITED STATES OF AMERICA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clare, Robert Wayne, PA 8 79
Cooperstone, Brenda Bryn Mawr, PA 1 30
Stanley, George Surrey, GB 2 48

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation